SCHEMBL4921901

SCHEMBL4921901

O=C(C=Cc1ccc(C(CCc2cccc(F)c2)NC(=O)NC(=O)c2ccccc2)cc1)NO

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
HDAC4 P56524 8/20 0.46
HDAC1 Q13547 7/20 0.46
HDAC3 O15379 6/20 0.46
HDAC2 Q92769 5/20 0.46
HDAC8 Q9BY41 5/20 0.46
HDAC6 Q9UBN7 5/20 0.46
HDAC7 Q8WUI4 4/20 0.46
HDAC10 Q969S8 4/20 0.46
HDAC11 Q96DB2 4/20 0.46
HDAC9 Q9UKV0 4/20 0.46
HDAC5 Q9UQL6 4/20 0.46
MEF2D Q14814 4/20 0.44
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
MAPK1 P28482 1/20 0.41
CYP2C19 P33261 1/20 0.41
MMP1 P03956 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4933486 0.90 HDAC2 (0.50) ALDH1A1SMN1; SMN2HDAC4HDAC1HDAC3
SCHEMBL4922692 0.90 ALDH1A1 (0.54) ALDH1A1SMN1; SMN2HDAC4HDAC1HDAC3
SCHEMBL4922546 0.89 LMNA (0.47) ALDH1A1SMN1; SMN2HDAC4HDAC1HDAC3
SCHEMBL4933386 0.87 HDAC8 (0.47) ALDH1A1SMN1; SMN2HDAC4HDAC1HDAC3
SCHEMBL4923053 0.86 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2HDAC4HDAC1HDAC3
SCHEMBL4930697 0.85 HDAC1 (0.52) ALDH1A1SMN1; SMN2HDAC4HDAC1HDAC3
SCHEMBL4922683 0.85 HDAC3 (0.49) ALDH1A1SMN1; SMN2HDAC4HDAC1HDAC3
SCHEMBL4930165 0.85 HDAC2 (0.52) ALDH1A1SMN1; SMN2HDAC4HDAC1HDAC3
SCHEMBL4931762 0.84 HDAC1 (0.51) ALDH1A1SMN1; SMN2HDAC4HDAC1HDAC3
SCHEMBL4931121 0.84 HDAC3 (0.46) ALDH1A1SMN1; SMN2HDAC4HDAC1HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080070954-A1 Acylurea Connected And Sulfonylurea Connected Hydroxamates S*BIO PTE LTD. (SG) 2008-03-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080070954-A1 Acylurea Connected And Sulfonylurea Connected Hydroxamates HDAC1, HDAC3, HDAC4 ALDH1A1 1020/4885SMN1; SMN2 2353/4885HDAC4 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.